Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Rheinstein

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
American Family Physician|September 15, 1993
MedWatch: the FDA medical products reporting programP H Rheinstein
American Family Physician|March 1, 1995
Significant FDA approvals in 1994P H Rheinstein
American Family Physician|March 1, 1993
Update on food labelingP H Rheinstein
Clinical Therapeutics|January 23, 1999
Overview of the US Food and Drug Administration's reform legislationP H Rheinstein
American Family Physician|September 1, 1992
Reporting of adverse drug events: a key to postmarketing drug safetyP H Rheinstein
American Family Physician|December 1, 1993
The generic drug approval processP H Rheinstein
American Family Physician|June 1, 1997
Significant FDA approvals in 1996P H Rheinstein
Journal Francais D'Ophtalmologie|January 30, 2022
Cannabis smoking and glaucoma in the UK Biobank cohortS Lehrer, P H Rheinstein
American Family Physician|July 1, 1995
Home test kits and monitorsP H Rheinstein, A Thomas
American Family Physician|June 24, 1998
Significant FDA approvals in 1997P H Rheinstein, B Akbari
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
American Family Physician|September 15, 1993
MedWatch: the FDA medical products reporting programP H Rheinstein
American Family Physician|March 1, 1995
Significant FDA approvals in 1994P H Rheinstein
American Family Physician|March 1, 1993
Update on food labelingP H Rheinstein
Clinical Therapeutics|January 23, 1999
Overview of the US Food and Drug Administration's reform legislationP H Rheinstein
American Family Physician|September 1, 1992
Reporting of adverse drug events: a key to postmarketing drug safetyP H Rheinstein
American Family Physician|December 1, 1993
The generic drug approval processP H Rheinstein
American Family Physician|June 1, 1997
Significant FDA approvals in 1996P H Rheinstein
Journal Francais D'Ophtalmologie|January 30, 2022
Cannabis smoking and glaucoma in the UK Biobank cohortS Lehrer, P H Rheinstein
American Family Physician|July 1, 1995
Home test kits and monitorsP H Rheinstein, A Thomas
American Family Physician|June 24, 1998
Significant FDA approvals in 1997P H Rheinstein, B Akbari
Pageof 4